장기 칩 시장 규모, 점유율, 성장 분석 : 장기 유형별, 모델 유형별, 제품 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Organ on Chip Market size was valued at USD 89.74 Billion in 2024 and is poised to grow from USD 117.34 Billion in 2025 to USD 1002.91 Billion by 2033, growing at a CAGR of 30.76% during the forecast period (2026-2033).

The organ-on-chip market is experiencing significant growth, driven by the demand for alternatives to animal testing and the urgency for early detection of drug reactions and toxicity. These microfluidic devices replicate specific organ functions, enabling applications in disease modeling, drug development, and toxicity assessment. Rapid technological advancements and increasing adoption across pharmaceuticals, biotech, and academic institutions are further propelling market expansion. Furthermore, as stakeholders explore new applications beyond traditional organs and improve integration into healthcare sectors, the market is expected to flourish. Enhanced research capabilities and the growing interest in organ-on-chip technologies, especially following the Covid-19 pandemic, indicate a robust future, with ongoing innovations anticipated to meet the evolving needs of the research community.

Top-down and bottom-up approaches were used to estimate and validate the size of the Organ on Chip market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Organ on Chip Market Segments Analysis

Global Organ On Chip Market is segmented by organ type, model type, product, purpose, application, end user and region. Based on organ type, the market is segmented into liver, kidney, intestine, lung, heart and other organs. Based on model type, the market is segmented into organ-based models and disease-based models. Based on product, the market is segmented into services and products. Based on purpose, the market is segmented into therapeutics and research. Based on application, the market is segmented into toxicology research, drug discovery, physiological model development, tissue regeneration ®enerative medicineand stem cell research. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, cosmetics industry, academic & research institutes and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Organ on Chip Market

There is a growing global movement advocating for alternatives to animal testing, which significantly impacts the Organ on Chip market. This heightened awareness among consumers is driving an increased demand for organ-on-chip platforms that facilitate drug discovery, toxicity testing, and other related applications. These innovative technologies offer humane, ethical, and efficient solutions that align with the desires of those seeking to eliminate animal experimentation. As the focus on ethical testing methods escalates, organ-on-chip systems are emerging as crucial tools, providing the potential to enhance research outcomes and revolutionize how pharmaceutical and biomedical industries approach testing processes.

Restraints in the Organ on Chip Market

The Organ-on-Chip market faces notable restraints due to ethical considerations related to the utilization of human cells, tissues, and organs in research. Concerns surrounding informed consent, privacy, and the ethical sourcing of biological materials complicate the industry landscape. It is crucial to navigate the legal and societal implications associated with this technology, including matters of animal welfare, to promote responsible innovation and sustainable practices within the market. Addressing these ethical dilemmas is essential for fostering public trust and ensuring that the development of organ-on-chip technologies aligns with societal values and norms, ultimately influencing their widespread acceptance and application.

Market Trends of the Organ on Chip Market

The Organ-on-Chip market is witnessing a notable trend toward enhancing drug safety and effectiveness predictions amidst the escalating costs and challenges faced by the pharmaceutical industry. As traditional methods prove inadequate, companies are increasingly adopting organ-on-chip technologies to provide more accurate, human-relevant data for drug testing. This innovative approach enables researchers to simulate human organ responses to therapeutic compounds, significantly reducing reliance on animal testing and improving predictive capabilities. Consequently, there is a growing investment in the development of sophisticated organ-on-chip models, which are anticipated to revolutionize the drug discovery process by streamlining research and accelerating time-to-market for new therapies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Case Study Analysis
• Trade Analysis
• Customer & Buying Criteria Analysis

Global Organ On Chip Market Size by Organ Type & CAGR (2026-2033)

• Market Overview
• Liver
• Kidney
• Intestine
• Lung
• Heart
• Other Organs

Global Organ On Chip Market Size by Model Type & CAGR (2026-2033)

• Market Overview
• Organ-Based Models
• Disease-Based Models

Global Organ On Chip Market Size by Product & Service & CAGR (2026-2033)

• Market Overview
• Services
  • Custom Services
  • Standard Services
• Products
  • Instruments
  • Consumables & Accessories
  • Software

Global Organ On Chip Market Size by Purpose & CAGR (2026-2033)

• Market Overview
• Therapeutics
• Research

Global Organ On Chip Market Size by Application & CAGR (2026-2033)

• Market Overview
• Toxicology Research
• Drug Discovery
• Physiological Model Development
• Tissue Regeneration & Regenerative Medicine
• Stem Cell Research

Global Organ On Chip Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical And Biotechnology Companies
• Cosmetics Industry
• Academic & Research Institutes
• Other End Users

Global Organ On Chip Market Size & CAGR (2026-2033)

• North America (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
  • US
  • Canada
• Europe (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Emulate, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mimetas B.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tissuse GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CN Bio Innovations Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSphero
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alveolix AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluigent
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations